| Rapid micro‐induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: a case series S Klaire, R Zivanovic, SP Barbic, R Sandhu, N Mathew, P Azar The American journal on addictions 28 (4), 262-265, 2019 | 111 | 2019 |
| Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority … JSH Wong, M Nikoo, JN Westenberg, JG Suen, JYC Wong, RM Krausz, ... Addiction Science & Clinical Practice 16, 1-10, 2021 | 44 | 2021 |
| Shifting North American drug markets and challenges for the system of care RM Krausz, JN Westenberg, N Mathew, G Budd, JSH Wong, VWL Tsang, ... International Journal of Mental Health Systems 15, 1-8, 2021 | 36 | 2021 |
| Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic E Zastepa, JC Sun, J Clune, N Mathew Journal of Substance Abuse Treatment 118, 108102, 2020 | 22 | 2020 |
| Behavioral health symptoms associated with chronic traumatic encephalopathy: a critical review of the literature and recommendations for treatment and research D Antonius, N Mathew, J Picano, A Hinds, A Cogswell, J Olympia, ... The Journal of Neuropsychiatry and Clinical Neurosciences 26 (4), 313-322, 2014 | 21 | 2014 |
| Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and … R Rafizadeh, M Danilewitz, CA Bousman, N Mathew, RF White, A Bahji, ... Journal of Psychopharmacology 37 (2), 135-143, 2023 | 15 | 2023 |
| An inside look at BC’s illicit drug market during the COVID-19 pandemic N Mathew, JSH Wong, RM Krausz BC Med J 63, 9-13, 2021 | 14 | 2021 |
| Shifting drug markets in North America-a global crisis in the making? M Meyer, JN Westenberg, KL Jang, F Choi, S Schreiter, N Mathew, C King, ... International journal of mental health systems 17 (1), 36, 2023 | 11 | 2023 |
| Towards an international consensus on the prevention, treatment, and management of high-risk substance use and overdose among youth M Krausz, JN Westenberg, V Tsang, J Suen, MJ Ignaszewski, N Mathew, ... Medicina 58 (4), 539, 2022 | 11 | 2022 |
| Developing a rapid transfer from opioid full agonist to buprenorphine:“Ultrarapid micro-dosing” proof of concept P Azar, N Mathew, D Mahal, JSH Wong, JN Westenberg, CG Schütz, ... Journal of Psychoactive Drugs 55 (1), 94-101, 2023 | 9 | 2023 |
| Treatment approaches and outcome trajectories for youth with high‐risk opioid use: A narrative review JN Westenberg, AMY Tai, J Elsner, MM Kamel, JSH Wong, P Azar, DX Vo, ... Early Intervention in Psychiatry 16 (3), 207-220, 2022 | 9 | 2022 |
| 48-Hour induction of transdermal buprenorphine to sublingual buprenorphine/naloxone: the IPPAS method P Azar, JSH Wong, N Mathew, M Vogel, J Perrone, AA Herring, ... Journal of Addiction Medicine 17 (2), 233-236, 2023 | 7 | 2023 |
| Case report: acute care management of severe opioid withdrawal with IV fentanyl P Azar, JN Westenberg, MJ Ignaszewski, JSH Wong, G Isac, N Mathew, ... Addiction Science & Clinical Practice 17 (1), 22, 2022 | 6 | 2022 |
| Improving residents’ performance on the PRITE: is there a role for peer-assisted learning? MT Mariano, N Mathew, P Del Regno, CA Pristach Academic Psychiatry 37, 342-344, 2013 | 6 | 2013 |
| Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine … R Rafizadeh, L Frankow, H Mahmood, S Poonia, N Mathew, M Danilewitz, ... Journal of Psychopharmacology 37 (10), 1040-1048, 2023 | 5 | 2023 |
| Cost Analysis of Buprenorphine Extended-Release Injection Versus Sublingual Buprenorphine/Naloxone Tablets in a Correctional Setting JSH Wong, S Masson, A Huang, D Romm, M Fong, T Porter, N Sharifi, ... Journal of Correctional Health Care 28 (6), 368-371, 2022 | 5 | 2022 |
| Prescription opioid use among seriously mentally ill veterans nationally in the veterans health administration N Mathew, RA Rosenheck Community mental health journal 52, 165-173, 2016 | 5 | 2016 |
| Medical assistance in dying: Aide médicale à mourir G Chaimowitz, A Freeland, GE Neilson, N Mathew, R Rasasingham, ... The Canadian Journal of Psychiatry 65 (9), 664-667, 2020 | 4 | 2020 |
| 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine P Azar, JSH Wong, N Mathew, MJ Ignaszewski, N Partovi, RM Krausz, ... Journal of Addiction Medicine 18 (1), 82-85, 2024 | 3 | 2024 |
| Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder P Azar, H Schneiderman, H Barron, JSH Wong, M Meyer, ... Addiction Science & Clinical Practice 19 (1), 50, 2024 | 1 | 2024 |
